Literature DB >> 25645465

Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region.

Silvia Sambugaro1, Mauro Di Ruvo, Maria Rosaria Ambrosio, Natalia S Pellegata, Mariaenrica Bellio, Alessandra Guerra, Mattia Buratto, Maria Pia Foschini, Federico Tagliati, Ettore degli Uberti, Maria Chiara Zatelli.   

Abstract

Genetic alterations frequently are involved in the development of a pituitary adenoma in young age. We here characterize the functional role of a deletion in CDKN1B 5'-UTR region (c.-29_-26delAGAG) identified in an acromegalic patient that developed a growth hormone in pituitary adenoma during childhood. Our results show that the identified novel heterozygous deletion in the CDKN1B 5'-UTR region associates with a reduction in CDKN1B mRNA levels, a predicted altered secondary mRNA structure, and a reduced CDKN1B 5'-UTR transcriptional activity in vitro. The patient displayed loss of heterozygosity in the same CDKN1B 5'-UTR region at tissue level and the 5'UTR region containing the deleted sequence encompasses a GRE. These findings indicate that the identification of functional alterations of newly discovered genetic derangements need to be fully characterized and always correlated with the clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645465     DOI: 10.1007/s12020-015-0540-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

Review 1.  Multiple endocrine neoplasia syndromes associated with mutation of p27.

Authors:  M Lee; N S Pellegata
Journal:  J Endocrinol Invest       Date:  2013-06-26       Impact factor: 4.256

2.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

3.  Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.

Authors:  Donatella Malanga; Silvia De Gisi; Miriam Riccardi; Marianna Scrima; Carmela De Marco; Mercedes Robledo; Giuseppe Viglietto
Journal:  Eur J Endocrinol       Date:  2011-11-30       Impact factor: 6.664

Review 4.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

5.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

6.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

7.  Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.

Authors:  S Takeuchi; H P Koeffler; D R Hinton; I Miyoshi; S Melmed; I Shimon
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

8.  Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.

Authors:  Gennaro Chiappetta; Carmela De Marco; Alfina Quintiero; Daniela Califano; Simona Gherardi; Donatella Malanga; Marianna Scrima; Cristina Montero-Conde; Letizia Cito; Mario Monaco; Maria Letizia Motti; Rosa Pasquinelli; Valter Agosti; Mercedes Robledo; Alfredo Fusco; Giuseppe Viglietto
Journal:  Endocr Relat Cancer       Date:  2007-06       Impact factor: 5.678

9.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

Review 10.  MENX and MEN4.

Authors:  Natalia S Pellegata
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more
  16 in total

1.  A giant? Think of genetics: growth hormone-producing adenomas in the young are almost always the result of genetic defects.

Authors:  Constantine A Stratakis
Journal:  Endocrine       Date:  2015-06-09       Impact factor: 3.633

Review 2.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

Review 3.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 4.  Pituitary gigantism: update on molecular biology and management.

Authors:  Maya B Lodish; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

Review 5.  Genetics of gigantism and acromegaly.

Authors:  Fady Hannah-Shmouni; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Growth Horm IGF Res       Date:  2016-08-10       Impact factor: 2.372

6.  Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.

Authors:  Simona Borsari; Elena Pardi; Natalia S Pellegata; Misu Lee; Federica Saponaro; Liborio Torregrossa; Fulvio Basolo; Elena Paltrinieri; Maria Chiara Zatelli; Gabriele Materazzi; Paolo Miccoli; Claudio Marcocci; Filomena Cetani
Journal:  Endocrine       Date:  2016-04-02       Impact factor: 3.633

7.  Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.

Authors:  Luciana A Naves; Adrian F Daly; Luiz Augusto Dias; Bo Yuan; Juliano Coelho Oliveira Zakir; Gustavo Barcellos Barra; Leonor Palmeira; Chiara Villa; Giampaolo Trivellin; Armindo Jreige Júnior; Florêncio Figueiredo Cavalcante Neto; Pengfei Liu; Natalia S Pellegata; Constantine A Stratakis; James R Lupski; Albert Beckers
Journal:  Endocrine       Date:  2015-11-25       Impact factor: 3.633

8.  Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.

Authors:  Fanny Chasseloup; Nathan Pankratz; John Lane; Fabio R Faucz; Margaret F Keil; Prashant Chittiboina; Denise M Kay; Tara Hussein Tayeb; Constantine A Stratakis; James L Mills; Laura C Hernández-Ramírez
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

9.  Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease.

Authors:  Laura C Hernández-Ramírez; Ryhem Gam; Nuria Valdés; Maya B Lodish; Nathan Pankratz; Aurelio Balsalobre; Yves Gauthier; Fabio R Faucz; Giampaolo Trivellin; Prashant Chittiboina; John Lane; Denise M Kay; Aggeliki Dimopoulos; Stephan Gaillard; Mario Neou; Jérôme Bertherat; Guillaume Assié; Chiara Villa; James L Mills; Jacques Drouin; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-05-22       Impact factor: 5.678

10.  MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.

Authors:  Amanda Seabrook; Ayanthi Wijewardene; Sunita De Sousa; Tang Wong; Nisa Sheriff; Anthony J Gill; Rakesh Iyer; Michael Field; Catherine Luxford; Roderick Clifton-Bligh; Ann McCormack; Katherine Tucker
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.